Inspire Corporate Bond ETF (IBD)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Inspire Corporate Bond ETF (IBD) trades at $23.77 with AI Score 44/100 (Grade C). Inspire Corporate Bond ETF (IBD) focuses on investing in investment-grade corporate bonds of biblically aligned U. S. companies. Market cap: $467.31M, Sector: Financial services.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for IBD: IBD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates IBD against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
IBD: the 1 perspectives are evenly split.
How is this calculated? →Inspire Corporate Bond ETF (IBD) Financial Services Profile
Inspire Corporate Bond ETF (IBD) offers exposure to investment-grade corporate bonds from biblically aligned U.S. companies, tracking the Inspire Corporate Bond Index. With a focus on ethical investing, IBD provides a unique fixed-income option for investors seeking values-based alignment within their portfolios, operating in the competitive asset management landscape.
What Is the Investment Thesis for IBD?
Inspire Corporate Bond ETF (IBD), with a market capitalization of $467.31M, presents a targeted investment in investment-grade corporate bonds of biblically aligned U.S. companies. The ETF's value proposition lies in its unique ethical screening process and adherence to the Inspire Corporate Bond Index. A key growth catalyst is the increasing investor demand for ESG (Environmental, Social, and Governance) and values-based investment products. However, the fund's performance is subject to interest rate risk and credit risk associated with the underlying bonds. Ongoing monitoring of the fund's expense ratio and tracking error relative to its benchmark is crucial for assessing its long-term value. The absence of a dividend yield may deter some income-seeking investors.
Based on FMP financials and quantitative analysis
IBD Key Highlights
- Market capitalization of $467.31M indicates a moderate size within the ETF market.
- Beta of 0.65 suggests lower volatility compared to the overall market, potentially appealing to risk-averse investors.
- Focus on investment-grade corporate bonds provides a relatively stable fixed-income investment.
- Ethical screening process aligns with the growing demand for values-based investing.
- Replicates the Inspire Corporate Bond Index, offering a transparent and rules-based investment approach.
Who Are IBD's Competitors?
IBD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BGRN iShares USD Green Bond ETF | $47.36 | +0.06% | $478.99M | 44 |
| FDHY FIDELITY ENHANCED HIGH YIELD ETF | $49.13 | +0.06% | $523.83M | 44 |
| HYEM VanEck Emerging Markets High Yield Bond ETF | $20.05 | +0.12% | $511.83M | 44 |
| HYGH iShares Interest Rate Hedged High Yield Bond ETF | $86.45 | +0.07% | $530.33M | 44 |
| IBTL iShares iBonds Dec 2031 Term Treasury ETF | $20.12 | +0.00% | $562.60M | 44 |
| NXDT NexPoint Diversified Real Estate Trust | $5.53 | +3.08% | $285.77M | 73 |
| GENB Generate Biomedicines, Inc. | $17.03 | -2.18% | $2.18B | 72 |
| SII Sprott Inc. | $118.11 | +2.72% | $3.05B | 71 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are IBD's Key Strengths?
- Unique focus on biblically aligned companies.
- Growing demand for ESG investments.
- Transparent and rules-based investment approach.
- Relatively stable fixed-income investment.
What Are IBD's Weaknesses?
- Limited investment universe compared to broad-based bond ETFs.
- Potential for higher expense ratio due to ethical screening process.
- Lack of dividend yield may deter some investors.
- Vulnerability to interest rate risk.
What Could Drive IBD Stock Higher?
- Increasing investor demand for ESG and values-based investments.
- Growing awareness of biblically responsible investing (BRI) principles.
- Potential for new partnerships with faith-based organizations.
- Launch of new ethically screened investment products.
What Are the Key Risks for IBD?
- Interest rate risk associated with fixed-income investments.
- Credit risk related to the underlying corporate bonds.
- Competition from larger asset managers with lower expense ratios.
- Changes in the Inspire Corporate Bond Index methodology.
- Market volatility and economic uncertainty.
What Are the Growth Opportunities for IBD?
- Expansion of ESG Investing: The increasing focus on ESG (Environmental, Social, and Governance) factors in investment decisions presents a significant growth opportunity for IBD. As more investors seek to align their portfolios with their values, the demand for ethically screened bond funds is likely to rise. The global ESG assets under management are projected to reach $50 trillion by 2025, indicating a substantial market opportunity. IBD can capitalize on this trend by further promoting its biblically responsible investing (BRI) approach and attracting investors seeking values-based fixed-income options.
- Partnerships with Faith-Based Organizations: Collaborating with faith-based organizations and financial advisors can expand IBD's reach to a wider audience of values-driven investors. By partnering with religious institutions, charities, and other organizations that share its values, IBD can tap into established networks and build trust with potential investors. This strategy can involve offering educational resources, hosting webinars, and participating in conferences and events focused on faith and finance. Successful partnerships can significantly increase IBD's visibility and market share within the faith-based investment community.
- Development of New Ethically Screened Products: Expanding its product line to include other ethically screened fixed-income and equity ETFs can attract a broader range of investors. By offering a suite of investment products that align with different risk profiles and investment objectives, IBD can cater to a wider segment of the values-based market. This can involve launching ETFs focused on specific sectors, such as healthcare or technology, or developing diversified portfolios that combine ethically screened stocks and bonds. Innovation in product development can enhance IBD's competitiveness and brand recognition within the ESG investment landscape.
- Increased Marketing and Awareness Campaigns: Implementing targeted marketing campaigns to raise awareness of IBD's unique value proposition can attract new investors. This can involve utilizing social media, online advertising, and public relations to communicate the fund's ethical screening process and investment performance. Highlighting the positive impact of investing in biblically aligned companies can resonate with values-driven investors and differentiate IBD from its competitors. Effective marketing can increase investor interest and drive asset growth for the fund.
- Geographic Expansion: While currently focused on U.S. companies, expanding the investment universe to include international companies that meet Inspire Investing's ethical criteria can broaden IBD's appeal to global investors. This can involve developing new indices and ETFs that track the performance of biblically aligned companies in other countries or regions. Geographic expansion can diversify IBD's portfolio and tap into new markets with growing demand for ESG investments. However, it also requires careful consideration of regulatory and cultural differences in different countries.
What Opportunities Does IBD Have?
- Expansion of ESG investing.
- Partnerships with faith-based organizations.
- Development of new ethically screened products.
- Increased marketing and awareness campaigns.
What Threats Does IBD Face?
- Competition from larger asset managers with broader product offerings.
- Changes in interest rates and credit spreads.
- Regulatory changes impacting ESG investing.
- Negative publicity related to companies in the portfolio.
What Are IBD's Competitive Advantages?
- Unique ethical screening process based on biblical values.
- Alignment with the Inspire Corporate Bond Index.
- Brand recognition within the faith-based investment community.
- First-mover advantage in the biblically responsible investing (BRI) space.
What Does IBD Do?
The Inspire Corporate Bond ETF (IBD) was created to provide investors with a fixed-income investment option that aligns with biblically responsible investing (BRI) principles. The fund invests in investment-grade corporate bonds issued by U.S. companies that meet specific criteria related to their adherence to biblical values. IBD seeks to replicate the performance of the Inspire Corporate Bond Index, which is designed to select companies that demonstrate a commitment to these values. The ETF's investment strategy involves screening potential investments based on factors such as corporate governance, environmental stewardship, and social responsibility, as defined by Inspire Investing's BRI framework. By focusing on investment-grade bonds, IBD aims to provide a relatively stable and lower-risk fixed-income option compared to high-yield or emerging market debt. The fund's portfolio typically includes bonds from a diverse range of sectors, reflecting the broad universe of U.S. corporations that meet Inspire Investing's ethical criteria. IBD's unique approach to fixed-income investing has attracted investors who prioritize both financial returns and alignment with their values.
What Products and Services Does IBD Offer?
- Invests in investment-grade corporate bonds.
- Focuses on companies aligned with biblical values.
- Tracks the Inspire Corporate Bond Index.
- Provides exposure to U.S. corporate debt market.
- Offers a fixed-income investment option.
- Screens companies based on ethical criteria.
- Aims to provide stable returns with lower risk.
How Does IBD Make Money?
- Generates revenue through management fees charged on assets under management (AUM).
- Invests in a diversified portfolio of investment-grade corporate bonds.
- Utilizes a rules-based approach to select companies that meet ethical criteria.
- Replicates the performance of the Inspire Corporate Bond Index.
What Industry Does IBD Operate In?
The Inspire Corporate Bond ETF (IBD) operates within the asset management industry, specifically focusing on fixed-income investments. The industry is characterized by a wide range of investment strategies, including passive and active management, as well as specialized approaches such as ESG investing. The competitive landscape includes large asset managers offering broad-based bond ETFs, as well as smaller firms specializing in niche strategies. Market trends include increasing demand for ESG investments, driven by growing awareness of social and environmental issues. IBD differentiates itself through its unique focus on biblically aligned companies, catering to a specific segment of values-based investors.
Who Are IBD's Key Customers?
- Individual investors seeking values-based investments.
- Financial advisors looking for ethically screened fixed-income options.
- Faith-based organizations and institutions.
- ESG-focused investors.
How Inspire Corporate Bond ETF Is Valued
Relative to its peer group, IBD's quantitative score of 44/100 is roughly in line with the peer average of 44/100.
IBD Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the ETF's long-term performance, indicating that key stakeholders believe in its potential.
- Community sentiment has shifted positively, with discussions highlighting the ETF's resilience amidst market volatility.
- Investors are increasingly drawn to corporate bonds as a safer investment alternative, benefiting ETFs like IBD.
- Recent commentary on the stability of corporate bonds supports a bullish outlook, as more investors seek yield in uncertain times.
Bear Case
- Concerns about rising interest rates could pressure bond prices, leading to skepticism about the ETF's short-term performance.
- Some community members express doubts regarding the ETF's ability to outperform traditional equity markets, highlighting potential opportunity costs.
- Recent market developments have led to increased caution among investors, with some viewing corporate bonds as less attractive.
- The ETF's performance is heavily dependent on corporate credit quality, and any negative news could impact investor sentiment significantly.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
IBD Latest News
-
IBD Live Q&A Recap And Key Stock Lists For May 15, 2026
Investor's Business Daily · May 16, 2026
-
IBD Stock Of The Day: Off-Grid Power Provider Solaris Nears Entry
Investor's Business Daily · May 15, 2026
-
Stock Market Winners Tend To Have The 'New' In Spades. Here's Where To Find Them.
Investor's Business Daily · May 15, 2026
-
Nvidia, Others Pop To Record Highs. These 13 Stocks Just Added To IBD Stock Lists
Investor's Business Daily · May 14, 2026
IBD Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IBD.
Price Targets
Wall Street price target analysis for IBD.
IBD MoonshotScore
What does this score mean?
The MoonshotScore rates IBD's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
IBD Live Q&A Recap And Key Stock Lists For May 15, 2026
IBD Stock Of The Day: Off-Grid Power Provider Solaris Nears Entry
Stock Market Winners Tend To Have The 'New' In Spades. Here's Where To Find Them.
Nvidia, Others Pop To Record Highs. These 13 Stocks Just Added To IBD Stock Lists
What Investors Ask About Inspire Corporate Bond ETF (IBD) — Financial Services
What does Inspire Corporate Bond ETF do?
Inspire Corporate Bond ETF (IBD) is a passively managed exchange-traded fund that invests in investment-grade corporate bonds issued by biblically aligned U.S. companies. The fund seeks to replicate the performance of the Inspire Corporate Bond Index, which screens companies based on their adherence to biblical values. IBD provides investors with a fixed-income investment option that aligns with their ethical and religious beliefs, offering exposure to a diversified portfolio of corporate bonds while adhering to specific moral and social criteria. The ETF's investment strategy focuses on companies that demonstrate a commitment to responsible corporate governance, environmental stewardship, and social responsibility, as defined by Inspire Investing's BRI framework.
What are the main risks for IBD?
The main risks for Inspire Corporate Bond ETF (IBD) include interest rate risk, which can negatively impact the fund's value when interest rates rise. Credit risk is also a concern, as the fund invests in corporate bonds that are subject to default risk. The fund's unique ethical screening process may limit its investment universe and potentially lead to lower returns compared to broad-based bond ETFs. Additionally, competition from larger asset managers with lower expense ratios poses a challenge to IBD's ability to attract and retain assets. Changes in the Inspire Corporate Bond Index methodology or negative publicity related to companies in the portfolio could also negatively impact the fund's performance.
What are the key factors to evaluate for IBD?
Inspire Corporate Bond ETF (IBD) holds an AI score of 44/100 (low). Not financial advice.
How frequently does IBD data refresh on this page?
IBD prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven IBD's recent stock price performance?
Inspire Corporate Bond ETF (IBD) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Unique focus on biblically aligned companies. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider IBD overvalued or undervalued right now?
Valuing Inspire Corporate Bond ETF (IBD) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying IBD?
Before investing in Inspire Corporate Bond ETF (IBD), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding IBD to a portfolio?
Key strength of Inspire Corporate Bond ETF (IBD): Unique focus on biblically aligned companies. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for IBD.
- Information is based on available data and may be subject to change.